0001493152-24-005356 Sample Contracts

AGREEMENT AND PLAN OF MERGER dated as of February 7, 2024 by and among Telix Pharmaceuticals Limited, CYCLONE Merger Sub I, Inc., CYCLONE Merger Sub II, Inc., QSAM BIOSCIENCES, INC. and

Merger Agreement • February 8th, 2024 • QSAM Biosciences, Inc. • Specialty cleaning, polishing and sanitation preparations • Victoria

• Contract Type
  Merger Agreement
• Filed
  February 8th, 2024
• Company
  QSAM Biosciences, Inc.
• Industry
  Specialty cleaning, polishing and sanitation preparations
• Jurisdiction
  Victoria

This Agreement and Plan of Merger (this “Agreement”), dated as of February 7, 2024, is entered into by and among Telix Pharmaceuticals Limited ACN 616 620 369, a public limited company registered under the Laws of the Commonwealth of Australia (“Buyer”), Cyclone Merger Sub I, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Buyer (“Merger Sub I”), Cyclone Merger Sub II, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Buyer (“Merger Sub II”, and together with Merger Sub I, “Merger Subs”), QSAM Biosciences, Inc., a Delaware corporation (the “Company”), and David H. Clarke, solely in his capacity as the Company Stockholder Representative hereunder.

QSAM Biosciences Signs Definitive Agreement to be Acquired by Telix Pharmaceuticals

Agreement and Plan of Merger • February 8th, 2024 • QSAM Biosciences, Inc. • Specialty cleaning, polishing and sanitation preparations

• Contract Type
  Agreement and Plan of Merger
• Filed
  February 8th, 2024
• Company
  QSAM Biosciences, Inc.
• Industry
  Specialty cleaning, polishing and sanitation preparations

Austin, TX; February 7, 2024 – QSAM Biosciences Inc. (OTCQB: QSAM) (“QSAM or the “Company”) has signed a definitive Agreement and Plan of Merger (the “Agreement”) providing for the acquisition of the Company by Telix Pharmaceuticals Limited (ASX: TLX) (“Telix”).